pennsylvania biotechnology center photobanner

Seminar Series Schedule 2013

An annual Seminar Series is co-sponsored by the Baruch S. Blumberg Institute, the Hepatitis B Foundation, and the Drexel Institute to promote scientific exchange at the national and international level.

12/19/13 – Michele Kutzler, PhD (Drexel University College of Medicine)
“Preclinical development of prophylactic HCV DNA Vaccines encoding NS3/4a, NS4b, NS5a, NS5b genotype 1a/1b consensus antigens”

12/5/13 – Grant Gallagher, PhD (Humigen, The Institute for Genetic Immunology)
“Interferon lands its birth and life”

12/3/13 – Jonathan Chernoff, MD, PhD (Fox Chase Cancer Center)
“p21-activated kinases as targets in cancer therapy”
PDDI’s 2013 Drug Discovery Award Recipient

11/25/13 – Dario Altieri, MD (The Wistar Institute)
“Cancer metabolomics”

11/21/13 – D. Craig Hooper, PhD (Thomas Jefferson University Medical College)
"Immune intervention in the CNS:  Lessons from rabies and glioma"

11/15/13 - Annual Biotech Conference* (Regional Biotech Council)
Consumer Product Development, an Alternative Path to Commercialization

11/7/13 – Qing Xu, PhD (Wuxi Apptec)
“In vitro plate-based screening platforms at Wuxi Apptec”

10/31/13 – Rick Scott, PhD (Fox Chase Chemical Diversity Center)
“Therapeutic Development of Non-Peptidic Mimics of the Host Defense Proteins”

10/30/13 – Jessica Weidner, PhD (Karolinska Institute)
“Tightly regulated migratory subversion of immune cells promotes the dissemination of Toxoplasma gondii”

10/29/13 – Sina Bavari, PhD (U.S. Army Medical Research Institute for Infectious Diseases)
“Defeating highly pathogenic viruses”

10/16/13 – Chad Dickey, PhD (University of South Florida College of Medicine)
“Anti-Tau Drug Development for the Treatment of Alzheimer’s Disease & Tauopathies”

10/10/13 – Mark Cockett, PhD (Bristol-Myers Squibb)
“Therapeutic Strategies toward Functional Cure of Chronic Viral Diseases”

10/2/13 – Entrepreneur Seminar (IHVR & Drexel U. Close Sch. of Entrepreneurship & Innovation)
“Four Stages of Life Sciences Ventures”

9/26/13 – PDDI Mini-Symposium “Entreprenuership: Drug Discovery Innovation at Start-Up, Small and Medium-Sized Biotechnology Companies”

9/19/13 - John Beutler, PhD (Center for Cancer Research, NCI)
"The Molecular Targets Lab: Utilizing NCI Cancer Biology, Natural Products, and HTS."

9/13/13 – John Williams, PhD (Parco Tecnologico Padano)
“Livestock genomics and genetics (at the Parco Tecnologico Padano ): Research and perspectives”

9/12/13 - Peter Bernstein, PhD (PhaRmaB, LLC)
“5HT1B-modulators: An elusive target for CNS Discovery and Development”

8/22/13 – James Arthos, PhD (National Institute of Allergy and Infectious Diseases, NIH)
“Glycosylation in HIV Transmission”

8/15/13 - Ramesh Akkina, DVM, PhD (Colorado State University)
"Modeling HIV prevention and therapies in new generation humanized mice"

8/8/13 – Mark Kester, PhD (Penn State University College of Medicine)
“Nano Solutions for HCC”

7/11/13 – Brian Haab, PhD (Van Andel Institute)
New glycan-detection reagents and bioinformatics of protein-glycan interactions.”

6/27/13 – Doron Greenbaum, PhD (University of Pennsylvania School of Medicine)
“A chemical biology approach to understand essential proteins for parasites”

6/13/13 - Daniela Zarnescu, Ph.D. (The University of Arizona)
“Flies in motion: What can Drosophila tell us about ALS?”        

6/4/13 – Oren Gilad, PhD1 & Ren Capocasale2* (1Atrin Pharmaceuticals & 2FlowMetric, Inc)
Biotech-CRO Strategic Partnering: A Method to Success.” 

5/30/13 – Gregory Adams, PhD (Fox Chase Cancer Center)
“Developing Optimized Antibodies for Cancer Therapy”

5/16/13 – Susan Ross, PhD (University of Pennsylvania Perelman School of Medicine)
“Identification of cellular genes involved in New World arenavirus entry”

5/14/13 – Claudia Cornwall, PhD* (Journalist)
“Catching Cancer: the scientists who found its infectious causes”

5/9/13 – Richard R. Drake, PhD (Medical University of South Carolina)
“Glycopharmacology – MALDI-MS imaging approaches for analysis of tumor glycan changes in response to novel lipid targeted therapies”

5/3/12 – Robert Purcell, MD (National Institute of Allergy and Infectious Diseases, NIH)
“The Golden Age of Hepatitis Research, a Jaundiced View of History”
Hepatitis B Foundation’s 2013 Baruch S. Blumberg Prize

4/25/13 – Alexander Mazin, PhD (Drexel University College of Medicine)
“New insights in regulation of human RAD51 activities”

4/18/13 – Sean Brady, PhD (The Rockefeller University)
"Watch where you step, there is new chemistry everywhere!"  

4/11/12 – Lishan Su, PhD (University of North Carolina School of Medicine)
“Modeling HBV/HCV immuno-pathogenesis and -therapy in humanized mice”

4/4/12 – Jorge Marrero, MD, MS (UT Southwestern Medical Center)
“Detecting Liver Cancer Early”
Hepatitis B Foundation’s 2013 Bruce Witte Lecturer

3/28/13 – George C. Prendergast, PhD (Lankenau Institute for Medical Research)
“’Acapreneurial’ Research in Cancer, Cardiovascular Disease and Diabetes at Lankenau”

3/26/13 – Shawn DeFrees, PhD* (Seneb BioSciences)
“Glycoprotein Therapeutics: Modifying Glycans to Improve Protein Performance”

3/7/13 – Lewis Roberts, MB, ChB, PhD (Mayo Clinic)
“Effects of Heparan Sulfate Sulfatases on Signaling Pathways in Liver Cancer”

2/28/13 – Liva Harinantenaina R.R., PhD (VirginiaTech College of Science)
“Bioactive compounds from Madagascan biota”

2/21/13 – Cynthia Maryanoff, PhD (Johnson & Johnson)
“Drug-eluting cardiovascular stents: dynamics of drug release from different polymer systems”

2/12/13 – Heather Steinman, PhD* (UPStart, University of Pennsylvania)
“Do’s and Don’ts of Tech Transfer:  Lessons Learned by Trial and Error”

1/31/13 – Glenn Rall, PhD (Fox Chase Cancer Center)
“How the Usual Suspects Result in Unusual Outcomes:  Interferon Signaling in Neurons”

1/23/13 – Nicholas Meanwell, PhD (Bristol Myers Squibb)
“The Design and Discovery of Inhibitors of Hepatitis C Virus NS3 Protease and NS5A”

1/10/13 - Yuntao Wu, Ph.D (George Mason University)     
“Chemotactic signaling and Arp2/3-dependent nuclear migration in HIV-1 infection”



Past Seminar Series






Hepatitis B Foundation
delaware college